Content overview: “Sanofi dodges EU fine after settling antitrust probe over disparaging rival flu vaccine”. Sanofi has avoided a potential European Union fine after antitrust regulators accepted the French drugmaker's offer to settle an investigation into claims it ran a misleading campaign that disparaged a rival flu vaccine. The European Commission, the EU's competition watchdog, had been probing whether Sanofi's marketing practices unfairly undermined a competing product, but the company's concessions were deemed sufficient to address competition concerns without formal penalties.
The case centered on Sanofi's promotional activities for its influenza vaccines, which allegedly included communications that cast doubt on the safety or effectiveness of a rival shot. While the Commission did not disclose the exact nature of the disparaging claims, the settlement means Sanofi will alter its marketing behavior moving forward, though no fine will be imposed. For the complete material, the listing points back to the source inside the network.